An award-winning health journalist and consultant, James Gormley has 20 years of experience in the natural products industry. He can be reached at email@example.com.
GMO Labeling in the Hot Seat
The U.S. House passed the Safe and Accurate Food Labeling Act in July. What’s the current status of GMO-labeling laws, and is federal GMO labeling now imminent?
Advice for the Next Head of FDA’s Division of Dietary Supplements
Two industry leaders offer advice to the next head of FDA’s Division of Dietary Supplements—whoever she or he may be.
When will FDA release revised NDI draft guidance?
July 4th is one expert’s prediction.
Dan Fabricant's FDA Insights
FDA's former dietary supplements division head is now back at the Natural Products Association. What agency insights does he bring back?
GMO-Labeling Laws: Why the Trigger Clause?
Connecticut and Maine's GMO-labeling bills are dormant until other states join in. Why?
A Questionable Codex
Codex Comission adopts reference values for 11 nutrients
How to Deal With the EU's Nutrition and Health Claims Regulation
Companies seem to be coping with the regulations through a variety of strategies.
A Non-DMAA World: The Status of DMAA in Today's Dietary Supplements Market
Has FDA effectively slammed the door shut on DMAA?
New York's New Sports Supplement Bill
A New York senator proposes a new bill targeting the sports performance market.
Prop 65 and Dietary Supplements: Finally, a Small Win for Industry?
A Superior Court judge rules in favor of a group of dietary supplement companies in a Prop 65 case.
By clicking Accept, you agree to become a member of the UBM Medica Community.